## Abstract Ductal carcinoma in situ (DCIS) accounts for approximately 20% of mammographically detected breast cancers. DCIS can recur or progress to invasive breast cancer, but the ability to predict the outcome of patients with DCIS remains limited, leading to inappropriate treatment choices. To
How to prevent invasive breast cancer: Detect and excise duct carcinoma in situ
β Scribed by Cady, Blake
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 51 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Currently there is one presumed method to prevent invasive breast cancer; detect, and excise, duct carcinoma in situ (DCIS). Just as removal of colon polyps prevents invasive colon cancer [1], and the detection and local treatment of carcinoma in situ of the cervix prevents invasive carcinoma of the cervix , accumulating data about DCIS suggest that the detection and complete excision of DCIS of the breast can prevent many, if not most, invasive ductal cancers (IDC). However, current reviews of prevention of breast cancer fail to define excision of DCIS as the only practical, established, and current method of prevention . Numerous lines of reasoning lead to this conclusion and support efforts to detect, by mammography screening, and treat, by excision, DCIS:
π SIMILAR VOLUMES
## Prognostic Significance of In Situ article: ''the greatest impact of IFN-a-2b was manifest early in the first year of treatment . . .''. If further data ## Carcinoma Associated with confirm this trend, it may be possible to shorten the Invasive Breast Carcinoma duration (and diminish the cost)
## BACKGROUND. Our previous studies indicate that the in situ phase of mammary carcinogenesis is characteristically associated with cell-mediated immunity (CMI) against an immunogen shared by most breast carcinomas. Such reactivity is inversely correlated with stage and appears to impede in situ-t
## Abstract A relatively nonβdestructive method employing Raman spectroscopy for the analysis of histopathological specimens is described. Raman spectroscopy has allowed qualitative analysis of the same specimen used for histopathological evaluation. Breast cancer tissues have been analysed to demo